| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/2009 | US20090105309 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation |
| 04/23/2009 | US20090105307 2-aminooxazolines as taar1 ligands |
| 04/23/2009 | US20090105306 Novel compounds as cannabinoid receptor ligands |
| 04/23/2009 | US20090105305 Therapeutic Agents - 550 |
| 04/23/2009 | US20090105304 Combination therapy for reducing side effects using cannabinoid receptor ligands |
| 04/23/2009 | US20090105303 Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 04/23/2009 | US20090105302 (2-Pyrazol-1-yl-5-trifluoromethylphenyl)carbamic acid 4-cyclopropanesulfonylamino-carbonyl-13-methyl-2,14-dioxo-3,13-diazatricyclo-[13.3.0.04,6]octadec-7-en-17-yl ester; viricides; potency, decreased cytotoxicity, improved pharmacokinetics, improved resistance profile; liver disorders; ritonavir |
| 04/23/2009 | US20090105301 9a-substituted azalides for the treatment of malaria |
| 04/23/2009 | US20090105300 AMINE LINKED MODULATORS OF y-SECRETASE |
| 04/23/2009 | US20090105299 c-MET MODULATORS AND METHODS OF USE |
| 04/23/2009 | US20090105298 Pharmaceutical composition for therapy of interstitial cystitis |
| 04/23/2009 | US20090105297 Compounds Modulating C-Kit Activity |
| 04/23/2009 | US20090105296 Inhibitors of c-fms kinase |
| 04/23/2009 | US20090105295 Hydroxylamine substituted imidazoquinolines |
| 04/23/2009 | US20090105294 Biosynthetic Gene Cluster for the Production of a Complex Polyketide |
| 04/23/2009 | US20090105293 Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 04/23/2009 | US20090105292 Glucocorticoid Receptor Modulator Compounds and Methods |
| 04/23/2009 | US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/23/2009 | US20090105290 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one-Compounds and the Use Thereof for Producing Drugs |
| 04/23/2009 | US20090105289 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds |
| 04/23/2009 | US20090105288 CARBON LINKED MODULATORS OF gamma-SECRETASE |
| 04/23/2009 | US20090105287 Inhibitors of Dihydrofolate Reductase With Antibacterial Antiprotozoal, Antifungal and Anticancer Properties |
| 04/23/2009 | US20090105286 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors |
| 04/23/2009 | US20090105285 Pharmaceutical combinations comprising a mtor inhibitor and a raf kinase inhibitor |
| 04/23/2009 | US20090105284 Aminocyclohexanes as Dipeptidyl Peptidase-IV for the Treatment or Prevention of Diabetes |
| 04/23/2009 | US20090105283 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| 04/23/2009 | US20090105282 Methods of treating benign prostatic hyperplasia or lower urinary tract symptoms by using pde 5 inhibitors |
| 04/23/2009 | US20090105281 Methods of treating inflammation |
| 04/23/2009 | US20090105280 Novel Aromatic Nitro Compounds |
| 04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
| 04/23/2009 | US20090105278 Selective inhibitors of human corticosteroid syntheses |
| 04/23/2009 | US20090105277 Agent for preventing and/or treating movement disorder |
| 04/23/2009 | US20090105276 Lindane lotion and methods |
| 04/23/2009 | US20090105275 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE |
| 04/23/2009 | US20090105274 Indolecarboxylic Acid Derivative Having PGD2 Receptor Antagonistic Activity |
| 04/23/2009 | US20090105273 Diacylglycerol Acyltransferase Inhibitors |
| 04/23/2009 | US20090105272 Prodrugs of modulators of ABC transporters |
| 04/23/2009 | US20090105271 Pyridyl sulfonamides as modulators of ion channels |
| 04/23/2009 | US20090105270 Kinase inhibition and anticancer therapy |
| 04/23/2009 | US20090105269 Multifunctional Compounds and Methods of Use Thereof |
| 04/23/2009 | US20090105268 Dihydropyrimidone Multimers and Their Use as Human Neutrophil, Elastase Inhibitors |
| 04/23/2009 | US20090105267 Octahydro-pyrrolo[3,4-b]pyrrole n-oxides |
| 04/23/2009 | US20090105266 Organic compounds |
| 04/23/2009 | US20090105265 Pharmaceutical Compositions of Combinations of Dipeptidyl Peptidase-4 Inhibitors With Metformin |
| 04/23/2009 | US20090105264 Substituted Nicotinamide Compounds |
| 04/23/2009 | US20090105263 Heterobicyclic compounds as glucokinase activators |
| 04/23/2009 | US20090105262 Bridged polycyclic compound based compositions for coating oral surfaces in humans |
| 04/23/2009 | US20090105261 Novel substituted pyrazolo[1,5<I>A</I>]-1,3,5-Triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
| 04/23/2009 | US20090105260 Molecules to Enhance Percutaneous Delivery and Methods for Discovery Therefor |
| 04/23/2009 | US20090105259 Acyclic 1,4-Diamines and Uses Thereof |
| 04/23/2009 | US20090105258 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 04/23/2009 | US20090105257 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 04/23/2009 | US20090105256 Prodrugs of ion channel modulating compounds and uses thereof |
| 04/23/2009 | US20090105255 Glucokinase activators |
| 04/23/2009 | US20090105254 Vhr protein tyrosine phosphatase inhibitors, compositions and methods of use |
| 04/23/2009 | US20090105253 Triazole Derivative and Use Thereof |
| 04/23/2009 | US20090105252 Pyrimidine Derivatives and Their Use in Therapy as well as the Use of Pyrimidine Derivatives in the Manufacture of a Medicament for Prevention and/or Treatment of Alzheimer's Disease |
| 04/23/2009 | US20090105251 Renin inhibitors |
| 04/23/2009 | US20090105250 Compounds and compositions as protein kinase inhibitors |
| 04/23/2009 | US20090105249 4-phenylsulfonamidopiperidines as calcium channel blockers |
| 04/23/2009 | US20090105248 3-monosubstituted tropane derivatives as nociceptin receptor ligands |
| 04/23/2009 | US20090105247 tert-butyl 4-((4-(3-ethynylphenylamino)quinazolin-6-ylcarbamoyl)methylene)piperidine-1-carboxylate, used for treating or preventing physiological disorder caused by epidermal growth factor receptor (EGFR) or ERBB/Her-2 gene overexpression in mammals; anticarcinogenic agents |
| 04/23/2009 | US20090105246 Sirtuin modulating compounds |
| 04/23/2009 | US20090105245 Methods for treating macular edema and ocular angiogenesis using an anti-inflammatory agent and a receptor tyrosine kinase inhibitor |
| 04/23/2009 | US20090105244 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor |
| 04/23/2009 | US20090105243 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 04/23/2009 | US20090105242 Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases |
| 04/23/2009 | US20090105241 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 04/23/2009 | US20090105240 Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same |
| 04/23/2009 | US20090105239 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 04/23/2009 | US20090105238 Compounds and Relative use for the Control of Phytopathogens |
| 04/23/2009 | US20090105237 Cooling compounds |
| 04/23/2009 | US20090105236 New pharmaceutically-active compounds for the treatment of respiratory diseases |
| 04/23/2009 | US20090105234 EP4 Receptor Agonist, Compositions and Methods Thereof |
| 04/23/2009 | US20090105233 Serine-threonine protein kinase and parp modulators |
| 04/23/2009 | US20090105232 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
| 04/23/2009 | US20090105231 Amide derivatives as rock inhibitors |
| 04/23/2009 | US20090105230 Anti-inflammatory medicaments |
| 04/23/2009 | US20090105229 Purine derivatives as kinase inhibitors |
| 04/23/2009 | US20090105228 Heterocyclic benzodiazepine cgrp receptor antagonists |
| 04/23/2009 | US20090105227 Thienopyrroles As Antiviral Agents |
| 04/23/2009 | US20090105226 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans |
| 04/23/2009 | US20090105225 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists |
| 04/23/2009 | US20090105224 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
| 04/23/2009 | US20090105223 Compound Having Activity Of Blocking NMDA Receptor Channel, and Pharmaceutical Agent Using The Same |
| 04/23/2009 | US20090105222 Prevention and treatment of functional somatic disorders, including stress-related disorders |
| 04/23/2009 | US20090105221 Muscarinic receptor antagonists |
| 04/23/2009 | US20090105220 Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives |
| 04/23/2009 | US20090105219 Spirolactam Tricyclic CGRP Receptor Antagonists |
| 04/23/2009 | US20090105218 CRTH2 Receptor Ligands For Therapeutic Use |
| 04/23/2009 | US20090105217 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands |
| 04/23/2009 | US20090105216 3- (aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors |
| 04/23/2009 | US20090105215 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 04/23/2009 | US20090105214 Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes |
| 04/23/2009 | US20090105213 Lactam compounds useful as protein kinase inhibitors |
| 04/23/2009 | US20090105212 Immunomoderators; antiallergens; viricides; bactericides; anticancer agents; rhinitis; hepatitis; skin disorders |
| 04/23/2009 | US20090105211 Inhibitors of hedgehog pathway |
| 04/23/2009 | US20090105210 Bicyclic Pyrimidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 04/23/2009 | US20090105209 BTK protein kinase inhibitors |
| 04/23/2009 | US20090105208 Substituted Piperazines as CB1 Antagonists |